2023 Updates on Lung Cancer — On Demand

Tuesday, November 21, 2023, 7:30 AM - Saturday, November 30, 2024, 8:30 AM

MSK's Physician Relations Team is pleased to offer a complimentary one-hour on demand update on lung cancer. This lecture series, hosted by MSK's Physician Relations Team and led by MSK faculty experts, aims to provide valuable updates and insights across a wide range of topics.

In the 2023 Updates on Lung Cancer session:

• Dr. Katherine Gray, MSK Thoracic Surgeon, will provide an update on Resectable Lung Cancer 
• Dr. Michael Hwang, MSK Thoracic Oncologist, will provide an update on Targeted Therapy for Lung Cancer 
• Dr. Daniel Gomez, MSK Radiation Oncologist, will provide an update on The Evolving Role of Radiation Therapy in the Context of Unresectable Lung Cancer: Where Are We Now and Where Are We Going?

This on demand is intended for physicians, surgeons, APPs, nurses, trainees, and other healthcare professionals interested in lung cancer.

Select the Course Content tab above to access to the previously recorded lectures and instructions for claiming credit. This on demand will be available through November 30, 2024.

1. State updated screening guidelines for lung cancer
2. Recognize the indications for lobar vs sublobar resections for lung cancer
3. Describe updates to multimodal treatment modalities, including immunotherapy in resectable lung cancer
4. Discuss the next generation sequencing
5. Recognize frontline options in stage IV disease
6. Identify treatment options in early stage or locally advanced disease
7. Describe standard of care treatment options in the context of unresectable lung cancer
8. Discuss ongoing trials examining the role of radiation therapy in the context of unresectable lung cancer

This on demand is complimentary.

Please note, to claim credit, you will be asked to sign in to the MSK CME Portal or create an account if you do not already have one. A CME certificate will be available after the course evaluation is submitted. Complete instructions are available by clicking the Course Content tab above.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Recorded/Review Date: November 15, 2023; Original Release Date: November 21, 2023; Termination Date: November 30, 2024

Katherine Gray, MD
Thoracic Surgeon

Michael Hwang, MD
Thoracic Oncologist

Daniel Gomez, MD, MBA
Radiation Oncologist

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.